PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32655375-0	2020	CB1 Cannabinoid Receptors Stimulate Gbetagamma-GRK2-Mediated FAK Phosphorylation at Tyrosine 925 to Regulate ERK Activation Involving Neuronal Focal Adhesions.	Tyrosine	84-92	protein tyrosine kinase 2	Homo sapiens	61-64	
32655375-3	2020	Here, immunoblotting analyses using antibodies against FAK phospho-Tyr 925 and ERK2 phospho-Tyr 204 demonstrated CB1-stimulated FAK 925 Tyr-P and ERK2 204 Tyr-P (0-5 min) which was followed by a decline in Tyr-P (5-20 min).	Tyrosine	67-70	protein tyrosine kinase 2	Homo sapiens	55-58	
32655375-3	2020	Here, immunoblotting analyses using antibodies against FAK phospho-Tyr 925 and ERK2 phospho-Tyr 204 demonstrated CB1-stimulated FAK 925 Tyr-P and ERK2 204 Tyr-P (0-5 min) which was followed by a decline in Tyr-P (5-20 min).	Tyrosine	67-70	protein tyrosine kinase 2	Homo sapiens	128-131	
32655375-3	2020	Here, immunoblotting analyses using antibodies against FAK phospho-Tyr 925 and ERK2 phospho-Tyr 204 demonstrated CB1-stimulated FAK 925 Tyr-P and ERK2 204 Tyr-P (0-5 min) which was followed by a decline in Tyr-P (5-20 min).	Tyrosine	92-95	protein tyrosine kinase 2	Homo sapiens	55-58	
32655375-3	2020	Here, immunoblotting analyses using antibodies against FAK phospho-Tyr 925 and ERK2 phospho-Tyr 204 demonstrated CB1-stimulated FAK 925 Tyr-P and ERK2 204 Tyr-P (0-5 min) which was followed by a decline in Tyr-P (5-20 min).	Tyrosine	92-95	protein tyrosine kinase 2	Homo sapiens	128-131	
32655375-3	2020	Here, immunoblotting analyses using antibodies against FAK phospho-Tyr 925 and ERK2 phospho-Tyr 204 demonstrated CB1-stimulated FAK 925 Tyr-P and ERK2 204 Tyr-P (0-5 min) which was followed by a decline in Tyr-P (5-20 min).	Tyrosine	92-95	protein tyrosine kinase 2	Homo sapiens	55-58	
32655375-3	2020	Here, immunoblotting analyses using antibodies against FAK phospho-Tyr 925 and ERK2 phospho-Tyr 204 demonstrated CB1-stimulated FAK 925 Tyr-P and ERK2 204 Tyr-P (0-5 min) which was followed by a decline in Tyr-P (5-20 min).	Tyrosine	92-95	protein tyrosine kinase 2	Homo sapiens	128-131	
32655375-5	2020	The FAK inhibitors Y11 and PF 573228 abolished FAK 925 Tyr-P and partially inhibited ERK2 204 Tyr-P. FAK 925 Tyr-P and ERK2 204 Tyr-P were adhesion-dependent, required an intact actin cytoskeleton, and were mediated by integrins, Flk-1 vascular endothelial growth factor receptors, and epidermal growth factor receptors.	Tyrosine	55-58	protein tyrosine kinase 2	Homo sapiens	4-7	
32655375-5	2020	The FAK inhibitors Y11 and PF 573228 abolished FAK 925 Tyr-P and partially inhibited ERK2 204 Tyr-P. FAK 925 Tyr-P and ERK2 204 Tyr-P were adhesion-dependent, required an intact actin cytoskeleton, and were mediated by integrins, Flk-1 vascular endothelial growth factor receptors, and epidermal growth factor receptors.	Tyrosine	55-58	protein tyrosine kinase 2	Homo sapiens	47-50	
32655375-5	2020	The FAK inhibitors Y11 and PF 573228 abolished FAK 925 Tyr-P and partially inhibited ERK2 204 Tyr-P. FAK 925 Tyr-P and ERK2 204 Tyr-P were adhesion-dependent, required an intact actin cytoskeleton, and were mediated by integrins, Flk-1 vascular endothelial growth factor receptors, and epidermal growth factor receptors.	Tyrosine	55-58	protein tyrosine kinase 2	Homo sapiens	47-50	
32655375-5	2020	The FAK inhibitors Y11 and PF 573228 abolished FAK 925 Tyr-P and partially inhibited ERK2 204 Tyr-P. FAK 925 Tyr-P and ERK2 204 Tyr-P were adhesion-dependent, required an intact actin cytoskeleton, and were mediated by integrins, Flk-1 vascular endothelial growth factor receptors, and epidermal growth factor receptors.	Tyrosine	94-97	protein tyrosine kinase 2	Homo sapiens	4-7	
32655375-5	2020	The FAK inhibitors Y11 and PF 573228 abolished FAK 925 Tyr-P and partially inhibited ERK2 204 Tyr-P. FAK 925 Tyr-P and ERK2 204 Tyr-P were adhesion-dependent, required an intact actin cytoskeleton, and were mediated by integrins, Flk-1 vascular endothelial growth factor receptors, and epidermal growth factor receptors.	Tyrosine	94-97	protein tyrosine kinase 2	Homo sapiens	4-7	
32655375-5	2020	The FAK inhibitors Y11 and PF 573228 abolished FAK 925 Tyr-P and partially inhibited ERK2 204 Tyr-P. FAK 925 Tyr-P and ERK2 204 Tyr-P were adhesion-dependent, required an intact actin cytoskeleton, and were mediated by integrins, Flk-1 vascular endothelial growth factor receptors, and epidermal growth factor receptors.	Tyrosine	94-97	protein tyrosine kinase 2	Homo sapiens	4-7	
32655375-6	2020	FAK 925 Tyr-P and ERK2 204 Tyr-P were blocked by the Gbetagamma inhibitor gallein, a GRK2 inhibitor, and GRK2 siRNA silencing, suggesting Gbetagamma and GRK2 participate in FAK-mediated ERK2 activation.	Tyrosine	8-11	protein tyrosine kinase 2	Homo sapiens	0-3	
32655375-6	2020	FAK 925 Tyr-P and ERK2 204 Tyr-P were blocked by the Gbetagamma inhibitor gallein, a GRK2 inhibitor, and GRK2 siRNA silencing, suggesting Gbetagamma and GRK2 participate in FAK-mediated ERK2 activation.	Tyrosine	8-12	protein tyrosine kinase 2	Homo sapiens	0-3	
32655375-7	2020	Together, these studies indicate FAK 925 Tyr-P occurs concurrently with CB1-stimulated ERK2 activation and requires the actin cytoskeleton and Gi/obetagamma-GRK2-mediated cross-talk between CB1, integrins, and receptor tyrosine kinases (RTKs).	Tyrosine	41-44	protein tyrosine kinase 2	Homo sapiens	33-36